Table 1 The characteristics of participants according to survival status.
Variables | Total participants (n = 3089) | Surviving participants (n = 1992) | Dead participants (n = 1097) | P-valuea |
|---|---|---|---|---|
Age, years | 60.46 (0.46) | 55.80 (0.58) | 71.43 (0.53) | < 0.0001 |
Gender, n (%) | < 0.0001 | |||
Female | 1630 (57.09) | 1132 (60.10) | 498 (50.00) | |
Male | 1459 (42.91) | 860 (39.90) | 599 (50.00) | |
Race, n (%) | < 0.0001 | |||
Non-Hispanic White | 1568 (69.88) | 841 (66.01) | 727 (78.99) | |
Non-Hispanic Black | 612 (12.17) | 432 (12.85) | 180 (10.56) | |
Mexican American | 475 (7.74) | 365 (9.45) | 110 (3.70) | |
Other Hispanic | 201 (4.06) | 158 (4.69) | 43 (2.58) | |
Other race | 233 (6.16) | 196 (7.00) | 37 (4.18) | |
Marital, n (%) | < 0.0001 | |||
Married | 1730 (59.15) | 1181 (62.03) | 549 (52.36) | |
Never married | 278 (9.71) | 225 (11.57) | 53 (5.35) | |
SDW | 1081 (31.14) | 586 (26.40) | 495 (42.30) | |
PIR, n (%) | 0.003 | |||
< 1.3 | 1038 (25.16) | 668 (24.41) | 370 (26.92) | |
1.3–1.85 | 495 (14.55) | 297 (13.20) | 198 (17.74) | |
> 1.85 | 1556 (60.29) | 1027 (62.39) | 529 (55.34) | |
Education, n (%) | < 0.001 | |||
High school grad or equivalent | 1017 (37.91) | 697 (39.93) | 320 (33.16) | |
Less than high school | 993 (23.48) | 587 (20.82) | 406 (29.77) | |
Some college or above | 1079 (38.60) | 708 (39.26) | 371 (37.07) | |
Smoke, n (%) | < 0.0001 | |||
Former | 1012 (32.45) | 564 (28.86) | 448 (40.91) | |
Never | 1569 (50.69) | 1085 (53.79) | 484 (43.38) | |
Now | 508 (16.86) | 343 (17.35) | 165 (15.71) | |
Hypertension, n (%) | < 0.0001 | |||
No | 843 (31.55) | 647 (37.61) | 196 (17.27) | |
Yes | 2246 (68.45) | 1345 (62.39) | 901 (82.73) | |
Diabetes, n (%) | < 0.0001 | |||
No | 1798 (62.33) | 1194 (65.91) | 604 (53.90) | |
Yes | 1291 (37.67) | 798 (34.09) | 493 (46.10) | |
Cardiovascular disease, n (%) | < 0.0001 | |||
No | 2240 (75.32) | 1584 (81.70) | 656 (60.30) | |
Yes | 849 (24.68) | 408 (18.30) | 441 (39.70) | |
CKD stage, n (%) | < 0.0001 | |||
Stage I | 920 (34.01) | 798 (42.38) | 122 (14.37) | |
Stage II | 739 (21.75) | 448 (19.93) | 291 (26.07) | |
Stage III | 1290 (40.54) | 687 (35.64) | 603 (52.17) | |
Stage IV | 102 (2.69) | 43 (1.59) | 59 (5.29) | |
Stage V | 38 (0.95) | 16 (0.46) | 22 (2.11) | |
TC, mmol/L | 5.01 (0.03) | 5.02 (0.03) | 4.98 (0.04) | 0.35 |
TG, mmol/L | 1.72 (0.04) | 1.71 (0.06) | 1.76 (0.04) | 0.49 |
uACR, mg/g | 187.72 (13.67) | 155.63 (13.30) | 263.29 (34.75) | 0.005 |
eGFR, mL/min/1.73 m2 | 74.90 (0.78) | 80.84 (1.01) | 60.93 (1.02) | < 0.0001 |
TyG | 8.86 (0.02) | 8.82 (0.03) | 8.94 (0.03) | 0.002 |
BMI | 30.11 (0.20) | 30.56 (0.27) | 29.04 (0.26) | < 0.001 |
TyG-BMI | 268.32 (2.20) | 271.36 (2.91) | 261.16 (2.80) | 0.01 |
